Hans O. Ueland
Bergen, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Outcomes of malignant orbital tumors: a 22-year Norwegian single-center series.
Journal: Frontiers in surgery
Published: April 22, 2026
Long-term Outcome After Correction of Lower Eyelid Retraction With Donor Sclera in Thyroid Eye Disease.
Journal: Plastic and reconstructive surgery. Global open
Published: July 29, 2025
Reply Re: "Blepharotomy Versus Levator Recession With Adjustable Sutures for Correction of Upper Eyelid Retraction in Thyroid Eye Disease".
Journal: Ophthalmic plastic and reconstructive surgery
Published: June 12, 2025
Exploring tear fluid biomarkers and the ocular surface in thyroid eye disease.
Journal: Acta ophthalmologica
Published: April 24, 2025
Insight into the metabolic shifts in Graves' hyperthyroidism: a study of acylcarnitine and lipid profiles.
Journal: European thyroid journal
Published: January 03, 2025
Entropion.
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
Published: December 18, 2024
Strabismus surgery in topical anaesthesia with intraoperative suture adjustment in Graves' orbitopathy.
Journal: Acta ophthalmologica
Published: June 28, 2024
Blepharotomy Versus Levator Recession With Adjustable Sutures for Correction of Upper Eyelid Retraction in Thyroid Eye Disease.
Journal: Ophthalmic plastic and reconstructive surgery
Published: February 12, 2024
Ectropion.
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
Published: January 23, 2024
Molecular Biomarkers in Thyroid Eye Disease: A Literature Review.
Journal: Ophthalmic plastic and reconstructive surgery
Published: December 06, 2023
Outcomes of Patients With Graves Disease 25 Years After Initiating Antithyroid Drug Therapy.
Journal: The Journal of clinical endocrinology and metabolism
Published: June 18, 2023
Prevalence, Risk Factors, and Clinical and Biochemical Characteristics of Alemtuzumab-Induced Graves Disease.
Journal: The Journal of clinical endocrinology and metabolism
Published: May 24, 2023
Last Updated: 09/26/2026